| INTRODUCTION
Influenza infections are responsible for substantial morbidity during most seasons. [1] [2] [3] [4] [5] [6] [7] Influenza-associated illnesses are difficult to count because symptoms are non-specific, diagnostic codes associated with influenza-related symptoms are broad, and sensitive and specific laboratory testing for influenza is not routine. Many studies have estimated rates of serious complications of influenza infections-including hospitalizations and deaths-with statistical models. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] Modeling these outcomes is routine because severe influenza sequelae are uncommon, and confirmation of infection in such patients may be difficult, even with modern diagnostics. By contrast, influenza-associated outpatient visits are plentiful, so rates of laboratory-confirmed visits should be easier to document. However, relatively few studies have made populationbased estimates of influenza-confirmed outpatient visit rates. [12] [13] [14] [15] [16] [17] Most have focused on children, typically in a single site. 12, [14] [15] [16] [17] Often, few influenza-confirmed cases are reported (range, 90-372), 12, 13, 15, 17 resulting in wide confidence intervals (CIs) around rate estimates. While a key characteristic of influenza is season-to-season variability in intensity and severity, most studies have focused on a few seasons, 12, 13, 17, 18 or reported summary estimates from multiple seasons. [14] [15] [16] Finally, studies testing for influenza per protocol are not common, 12, 13, 15, 17 as prospective studies are resource-intensive. Thus, such studies are rarely conducted in large populations including persons of all ages, in multiple sites, or during multiple influenza seasons.
The 2009 influenza A(H1N1) pandemic highlighted a lack of US population-based rates of medically attended influenza-associated ill-
nesses. The Centers for Disease Control and Prevention (CDC) and
National Institute of Health estimated pandemic-associated illnesses, hospitalizations, and deaths, [19] [20] [21] [22] but few estimates of the incidence of influenza-like outpatient illnesses associated with H1N1pdm09 infection are available. 23 Without consistently made estimates of influenzarelated outpatient visits, the complete health burden of influenza cannot be established.
We used electronic health data from 6 integrated healthcare delivery organizations (hereafter, sites) participating in the CDC- 
| METHODS

| Study population
The VSD was established in 1990 to monitor vaccine safety in the US childhood immunization program. 24, 25 It has since expanded in size and scope. Currently, there are 8 participating integrated healthcare delivery systems that enroll about 10 million persons of all ages, or ~3% of the US population. Standardized data files with demographic information, enrollment history, healthcare utilization, and mortality data are maintained at each participating site, and accessed via a distributed data model to ensure confidentially; data quality checks are performed weekly to evaluate the quality of vaccination and medical encounter data. 26 An assessment of possible differences between the insured VSD population and the overall US population found no substantial differences by sex, race, ethnicity, or educational attainment; adults aged 55 through 64 years were slightly over-represented in VSD data. 27 A review of active vaccine adverse event detection systems noted the pioneering role of the VSD, how it has served as a model for systems in other countries, and its continuing innovation in data management and study design. 
| Human subjects
Institutional review boards at each of the 6 sites reviewed and approved the study protocol. 
| Viral surveillance data
| ICD-9-CM-coded outpatient visits
We analyzed weekly outpatient visits listing ICD-9-CM codes for 
| Models for estimating influenza-associated outpatient visits
We fit age-and site-specific negative binomial regression models to weekly outpatient visits coded for pneumonia or respiratory diseases. 5 To estimate influenza-associated pneumonia or respiratory, we started with visits predicted by a full model incorporating all viral terms and those predicted by a model in which an influenza covariate was set to 0, as previously described. 7 Weekly site-and age-specific numbers of estimated influenza-associated outpatient visits for each site were the sum of predicted pneumonia or respiratory visits and visits coded specifically for influenza. Annual age-specific incidence estimates were calculated as the sum of estimated outpatient visits in that age group divided by the sum of enrollments from the 6 participating sites. We estimated 95% confidence intervals (CIs) for each rate using 2.5th and 97.5th percentiles from a distribution derived from 10 000 bootstrap simulations. 
| Comparisons of estimated influenzaassociated outpatient visits with RT-PCR-confirmed influenza rates
To check the validity and precision of rates estimated as described above, we compared them with rates derived in 2 studies that tested outpatients for influenza infection using RT-PCR. Marshfield
Clinic rate estimates were compared with rates obtained using data from annual influenza vaccine effectiveness (VE) studies conducted there. 32, 33 In VE studies, patients presenting with acute respiratory symptoms were approached for enrollment; if consented, a respiratory specimen was collected and tested with CDC-approved Table 2 ). The highest rates for outpatient visits coded for influenza occurred in children aged 2-17 years, followed by children aged <2 years; the lowest rates occurred among persons aged ≥65 years. Rates for pneumonia/influenza and respiratory outpatient visits were highest among children aged <2 years, followed by persons aged 2-17 years or 65 years and older, while the lowest rate was among adults aged 18-49 years.
| Estimates of influenza-associated outpatient visits
Among persons of all ages, the annual mean rate of influenzaassociated visits estimated with models using pneumonia-coded vis- (Table 3) . During non-pandemic and pandemic seasons, rates were higher among younger persons.
In pre-pandemic seasons, the highest rate was 67 (95% CI, 49-164) per 10 000 person-years in children aged <2 years. The lowest rate was 25 (95% CI, 20-48) for persons aged ≥65 years. The highest rate during the pandemic was 381 (95% CI, 366-481) in children aged 2-17 years; the lowest rate was 63 (95% CI, 56-86) per 10 000 person-years for individuals aged ≥65 years. We found variability by site as well as by age group in estimated rates, but as no consistent patterns of geographic variability were noted (Table S1 ), we focused on the clear variability in rates by age group.
The annual mean rate of influenza-associated visits estimated with models using respiratory-coded visits was 185 (95% CI, 161-255) per 10 000 person-years during pre-pandemic seasons and 542 (95% CI, 441-823) per 10 000 person-years during the pandemic (Table 3) . During non-pandemic seasons, the highest rate was 375 (95% CI, 338-476) per 10 000 person-years in children aged 2-17 years, while the lowest rate was 78 (95% CI, 54-115) in persons aged ≥65 years. Similarly, during the pandemic, the highest rate was in children aged 2-17 years and the lowest rate was in persons aged ≥65 years.
Age-specific rates during the pandemic and pre-pandemic seasons and incidence rate ratios are provided in 
| Rate comparisons
Our estimates of influenza-associated outpatient visits among persons aged ≥50 years at Marshfield Clinic were similar to rates of RT-PCR-confirmed influenza visits calculated with VE study data ( Table 4) . Rates of RT-PCR-confirmed influenza visits each season fell within the 95% CIs of our model-based estimates in 4 of 5 seasons.
During the mild 2005-06 season, our estimated rate made with pneumonia visits was significantly greater than the rate from the VE study.
During the pandemic, rates estimated with pneumonia were similar to rates of RT-PCR-confirmed Influenza among subjects enrolled in the IISP. Figure 2 plots our estimated weekly rates and weekly rates of influenza-associated ILI from IISP. The timing, peak, and magnitude of these rates were consistent among both children aged 0-17 years and adults aged 18 and older.
| DISCUSSION
We estimated influenza-associated outpatient visit rates in 6 US healthcare organizations enrolling ~7.7 million persons and found that rates were greater among children and young persons during pre-pandemic and pandemic influenza seasons. The 2009-10 pandemic was associated with significant increases in rates of influenzaassociated outpatient visits in each of 5 age groups when compared with rates from preceding seasons. These increases were most pronounced in children, as expected.
T T A B L E 2 Annual rates of outpatient visits per 10 000 person-years for 3 categories of respiratory illnesses, by age group, among 6 US healthcare delivery systems Cross-protective immunity in older persons from prior infections with H1N1 viruses more closely related antigenically to the pandemic strain than H1N1 viruses circulating since 1977 contributed to these findings. 35 We estimated influenza-associated outpatient visits by add- Rate is calculated as the sum of estimated outpatient visits divided by the sum of enrollments from 6 participating sites. CI, denotes confidence interval generated by bootstrap simulation.
a Specific ICD-9-CM codes for influenza, pneumonia, and respiratory illness categories provided in the Methods.
T A B L E 2 (Continued)
T A B L E 3 Annual rates of influenza-associated outpatient visits per 10 000 person-years estimated with negative binomial regression models, by age group, among 6 US healthcare systems Rate is calculated as the sum of estimated outpatient visits divided by the sum of enrollments from 6 participating sites. CI, denotes confidence interval generated by bootstrap simulation.
symptoms, and not on the basis of ICD-9-CM diagnosis codes recorded after medical care. It is possible also that during milder influenza seasons, ICD codes may be less useful for identifying influenza cases. Based on these comparisons, we believe that future modeling studies should attempt to include more mild influenza seasons, as data from a broad range of seasons should permit better calibration of statistical models, and prevent possible overestimation of influenza-mediated events.
The second source of PCR-confirmed data was limited to the pandemic season. Estimated rates based on pneumonia-coded visits in the 6 participating sites were broadly consistent with rates of RT-PCR-confirmed influenza in the IISP study, which tested outpatients presenting with ILI. 23 As the ILI syndrome likely does not detect all illnesses that may be associated with influenza infections, this PCRbased estimate is conservative, suggesting that our pneumonia-based estimates are also conservative. Data from studies using sensitive diagnostics among a more inclusive set of signs and symptoms of influenza would be helpful.
More model-based estimates of influenza-associated outpatient visits should be compared with data from studies using RT-PCR or other highly sensitive diagnostics. The generalizability of this study's findings (and its underlying models) is limited by the paucity of comparison data. For example, the pandemic season was unusualincreased healthcare utilization consistent with intense media coverage was noted in 1 study site 36 -and comparisons made then may not be applicable during interpandemic periods. In Marshfield, comparison data were available only for older adults. Overall, our results suggest that models developed for more severe influenza outcomes yield influenza outpatient rate estimates that appear consistent with rates calculated with data collected in protocol-based studies using stateof-the-art diagnostics.
Our estimated rates of influenza-associated outpatient are somewhat lower than rates reported in some other studies. Poehling et al 17 reported that among children aged <2 years in 3 sites, the incidence of outpatient visits attributable to influenza among children was 280-520 per 10 000 during 2002-03 and 590-1250 per 10 000 during 2003-04. For the same age group, we estimated influenzaassociated respiratory visit rates were 197 per 10 000 and 377 per 10 000 in these 2 seasons, respectively. Besides the usual caveats regarding differences in study design affecting incidence estimates, it is possible that geographic differences in influenza activity also affected these comparisons. Poehling's study had 3 sites and ours 6; neither had the population size or geographic variation for its estimates to be interpreted as national in scope. We did find variation among our sites in estimated rates (Table S1 ); however, no clear age-specific patterns of differences by geography were apparent. Although estimated rates may be difficult to compare because of differences in study design, populations studied, seasons included, and geography, rate ratios between age groups should be similar. Here our findings are consistent with those from other studies 12, [14] [15] [16] [17] 23 : Young children bear the brunt of the outpatient influenza burden. Finally, although our study included >7 million persons, a larger population than other US studies, all data were from integrated health systems. Thus, at least with respect to age, our population is unlikely to fully represent the US population. 27 The generalizability of our findings to other US populations, like the uninsured and those covered by the Department of Veterans Affairs, may be more limited.
F I G U R E 1 Estimated rates of outpatient visits in 6 US healthcare delivery organizations (by age group) per 10 000 person-years (left yaxis) for influenza-associated pneumonia and influenza (Panel A) and respiratory diseases (Panel B); and pandemic-to-pre-pandemic rate ratios (right y-axis): solid line, rate ratio; dashed line, pandemic rate; and dotted line, pre-pandemic rate
T A B L E 4 Annual influenza-associated outpatient visits per 10 000 persons aged ≥50 y at Marshfield Clinic, estimated (i) using negative binomial models with pneumonia and influenza data; and (ii) using RT-PCR-confirmed influenza outpatient visits in annual influenza vaccine effectiveness studies The lower confidence limit is defined by a rate established by visits listing the ICD-9-CM code for influenza.
In addition to the issues noted above, we acknowledge other limitations. While we did adjust for RSV activity by including a weekly term for this virus in all models, we could not consider the effects of other viral or bacterial respiratory pathogens on influenza estimates.
Because RSV circulation often overlaps with influenza circulation and it is the leading cause of infectious respiratory disease among in young children, 6, 37 we emphasized adjusting for regional RSV activity.
Because the onset, duration, and intensity of influenza virus circulation vary geographically, 38 
